BASF Plant Science takes Amflora case to EU Court
BASF filed action against the EU Commission for failure to act
"EU Commissioners have postponed Amflora's approval despite repeated positive safety assessments by EFSA, the European Food Safety Authority. Although we welcome some positive signs by the Commission and President Barroso, such as their commitment to base decisions regarding genetically modified products purely on science, we are not prepared to accept any further delays," said Dr. Stefan Marcinowski, Member of the Board of Executive Directors of BASF SE.
"We are filing this case in order to ensure that European farmers and starch producers get access to an innovative product that offers them a potential added value of more than EUR100 million annually. In addition, we estimate that failure to approve Amflora is depriving BASF Plant Science of peak license income of EUR20 to 30 million per lost cultivation season," said Dr. Hans Kast, CEO and President of BASF Plant Science GmbH.
Most read news
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.